Recombinant COVID-19 Vaccine (Sf9 Cell)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Recombinant COVID-19 Vaccine (Sf9 Cell), covering 2024-04-24 to 2024-04-25. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Safety and Immunogenicity of the Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster [NA]